FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3138399382> ?p ?o ?g. }

• W3138399382 abstract "Abstract Evidence before this study It is emerging that long-term symptoms are often present in people who have had acute COVID-19 disease. These symptoms affect a range of organ systems including respiratory, cardiovascular and neurological systems. It is not clear how many patients who required hospitalisation develop these symptoms and the impact they have on quality of life. We searched PubMed on 24 th March 2021 using the terms ‘COVID-19’, ‘long-Covid’, ‘long-term’ and ‘outcomes’. This was supplemented by hand searching relevant references and news reports. We identified several small studies focussing on specific symptoms or diseases, studies of patients in community settings and studies of patients who were hospitalised for acute COVID-19 in Italy, Russia and China. There were no peer-reviewed published data at the time of searching which captured outcomes of patients within the United Kingdom. Added Value of this study We found that over half of patients reported not feeling fully recovered several months after onset of Covid-19 symptoms. The most common symptoms reported were fatigue, followed by breathlessness. Patients reported significant increases in new or worse disability, increases in MRC dyspnoea scale and worse quality of life as measured by EQ5D-5L summary index at the time of follow-up compared to before onset of acute COVID-19 symptoms. Our study found that women, in particular women under the age of 50 were significantly more likely to not feel fully recovered, were more breathless, more fatigued and had higher rates of new or worsened disability, even after taking severity of acute disease into account when compared to men of the same age. Implications of all available evidence Long-term symptoms following hospitalisation for COVID-19 are very common and have significant impacts on quality of life. Women under 50 were most likely to have the worst outcomes. Policy makers need to ensure there is long-term support for people experiencing long-Covid and should plan for lasting long-term population morbidity. Funding for research to understand mechanisms underlying long-Covid and identify potential interventions for testing in randomised trials is urgently required. Structured Abstract Background This study sought to establish the long-term effects of Covid-19 following hospitalisation. Methods 327 hospitalised participants, with SARS-CoV-2 infection were recruited into a prospective multicentre cohort study at least 3 months post-discharge. The primary outcome was self-reported recovery at least ninety days after initial Covid-19 symptom onset. Secondary outcomes included new symptoms, disability (Washington group short scale), breathlessness (MRC Dyspnoea scale) and quality of life (EQ5D-5L). Findings 55% of participants reported not feeling fully recovered. 93% reported persistent symptoms, with fatigue the most common (83%), followed by breathlessness (54%). 47% reported an increase in MRC dyspnoea scale of at least one grade. New or worse disability was reported by 24% of participants. The EQ5D-5L summary index was significantly worse at follow-up (median difference 0.1 points on a scale of 0 to 1, IQR: −0.2 to 0.0). Females under the age of 50 years were five times less likely to report feeling recovered (adjusted OR 5.09, 95% CI 1.64 to 15.74), were more likely to have greater disability (adjusted OR 4.22, 95% CI 1.12 to 15.94), twice as likely to report worse fatigue (adjusted OR 2.06, 95% CI 0.81 to 3.31) and seven times more likely to become more breathless (adjusted OR 7.15, 95% CI 2.24 to 22.83) than men of the same age. Interpretation Survivors of Covid-19 experienced long-term symptoms, new disability, increased breathlessness, and reduced quality of life. These findings were present in young, previously healthy working age adults, and were most common in younger females. Role of the funder: The study sponsors and funders had no role in the study design, collection, analysis, interpretation of data, writing of the report, or the decision to submit the article for publication. Investigators were independent from funders and the authors have full access to all of the data, including any statistical analysis and tables." @default.
• W3138399382 created "2021-03-29" @default.
• W3138399382 creator A5005269577 @default.
• W3138399382 creator A5014502334 @default.
• W3138399382 creator A5015120901 @default.
• W3138399382 creator A5015524131 @default.
• W3138399382 creator A5023171939 @default.
• W3138399382 creator A5027394200 @default.
• W3138399382 creator A5030523023 @default.
• W3138399382 creator A5032544139 @default.
• W3138399382 creator A5035855059 @default.
• W3138399382 creator A5038863766 @default.
• W3138399382 creator A5040122406 @default.
• W3138399382 creator A5043619164 @default.
• W3138399382 creator A5045250832 @default.
• W3138399382 creator A5048757776 @default.
• W3138399382 creator A5050637515 @default.
• W3138399382 creator A5053434980 @default.
• W3138399382 creator A5053761933 @default.
• W3138399382 creator A5054185332 @default.
• W3138399382 creator A5055086010 @default.
• W3138399382 creator A5055472937 @default.
• W3138399382 creator A5056005426 @default.
• W3138399382 creator A5056927941 @default.
• W3138399382 creator A5062217512 @default.
• W3138399382 creator A5062232887 @default.
• W3138399382 creator A5062294816 @default.
• W3138399382 creator A5070010761 @default.
• W3138399382 creator A5072180482 @default.
• W3138399382 creator A5074778109 @default.
• W3138399382 creator A5077452104 @default.
• W3138399382 creator A5084080194 @default.
• W3138399382 creator A5085113703 @default.
• W3138399382 creator A5086446779 @default.
• W3138399382 creator A5088826710 @default.
• W3138399382 creator A5090576757 @default.
• W3138399382 creator A5091696465 @default.
• W3138399382 creator A5091810575 @default.
• W3138399382 date "2021-03-23" @default.
• W3138399382 modified "2023-09-27" @default.
• W3138399382 title "Long Covid in adults discharged from UK hospitals after Covid-19: A prospective, multicentre cohort study using the ISARIC WHO Clinical Characterisation Protocol" @default.
• W3138399382 cites W2013851543 @default.
• W3138399382 cites W2124276457 @default.
• W3138399382 cites W2340244482 @default.
• W3138399382 cites W2461659346 @default.
• W3138399382 cites W2542519176 @default.
• W3138399382 cites W2728990317 @default.
• W3138399382 cites W2954806685 @default.
• W3138399382 cites W3009885589 @default.
• W3138399382 cites W3012948061 @default.
• W3138399382 cites W3013967887 @default.
• W3138399382 cites W3026764413 @default.
• W3138399382 cites W3034823740 @default.
• W3138399382 cites W3034858522 @default.
• W3138399382 cites W3041160585 @default.
• W3138399382 cites W3041493976 @default.
• W3138399382 cites W3046101830 @default.
• W3138399382 cites W3080487846 @default.
• W3138399382 cites W3120017613 @default.
• W3138399382 cites W3120387768 @default.
• W3138399382 cites W3128042479 @default.
• W3138399382 cites W3129430422 @default.
• W3138399382 cites W3135108774 @default.
• W3138399382 cites W4206588349 @default.
• W3138399382 cites W4292229870 @default.
• W3138399382 doi "https://doi.org/10.1101/2021.03.18.21253888" @default.
• W3138399382 hasPublicationYear "2021" @default.
• W3138399382 type Work @default.
• W3138399382 sameAs 3138399382 @default.
• W3138399382 citedByCount "18" @default.
• W3138399382 countsByYear W31383993822021 @default.
• W3138399382 countsByYear W31383993822022 @default.
• W3138399382 countsByYear W31383993822023 @default.
• W3138399382 crossrefType "posted-content" @default.
• W3138399382 hasAuthorship W3138399382A5005269577 @default.
• W3138399382 hasAuthorship W3138399382A5014502334 @default.
• W3138399382 hasAuthorship W3138399382A5015120901 @default.
• W3138399382 hasAuthorship W3138399382A5015524131 @default.
• W3138399382 hasAuthorship W3138399382A5023171939 @default.
• W3138399382 hasAuthorship W3138399382A5027394200 @default.
• W3138399382 hasAuthorship W3138399382A5030523023 @default.
• W3138399382 hasAuthorship W3138399382A5032544139 @default.
• W3138399382 hasAuthorship W3138399382A5035855059 @default.
• W3138399382 hasAuthorship W3138399382A5038863766 @default.
• W3138399382 hasAuthorship W3138399382A5040122406 @default.
• W3138399382 hasAuthorship W3138399382A5043619164 @default.
• W3138399382 hasAuthorship W3138399382A5045250832 @default.
• W3138399382 hasAuthorship W3138399382A5048757776 @default.
• W3138399382 hasAuthorship W3138399382A5050637515 @default.
• W3138399382 hasAuthorship W3138399382A5053434980 @default.
• W3138399382 hasAuthorship W3138399382A5053761933 @default.
• W3138399382 hasAuthorship W3138399382A5054185332 @default.
• W3138399382 hasAuthorship W3138399382A5055086010 @default.
• W3138399382 hasAuthorship W3138399382A5055472937 @default.
• W3138399382 hasAuthorship W3138399382A5056005426 @default.
• W3138399382 hasAuthorship W3138399382A5056927941 @default.
• W3138399382 hasAuthorship W3138399382A5062217512 @default.
• W3138399382 hasAuthorship W3138399382A5062232887 @default.
• W3138399382 hasAuthorship W3138399382A5062294816 @default.
• W3138399382 hasAuthorship W3138399382A5070010761 @default.

• next